On February 3, Bio-Thera Solutions signed a licensing and commercialization agreement with Saudi Arabia-based Avalon Pharma, granting it exclusive rights to commercialize BAT3306, a pembrolizumab ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results